Table 5.

Multivariate cox regression analysis for development of primary open angle glaucoma or retinal vein occlusion in subjects with and without the baseline diseases (either retinal vein occlusion or glaucoma, respectively).

Conditions	RVO → Glaucoma			Glaucoma → RVO
	Model 1	Model 2	Model 3	Model 1	Model 2	Model 3
	HR (95% CI)	HR (95% CI)	HR (95% CI)	HR (95% CI)	HR (95% CI)	HR (95% CI)
Baseline disease	3.38 (2.07–5.53)	2.80 (1.71–4.58)	2.89 (1.76–4.72)	7.34 (5.07–10.65)	5.93 (4.09–8.59)	5.93 (4.09–8.59)
Hypertension	2.48 (2.33–2.63)	1.93 (1.80–2.06)	1.93 (1.80–2.76)	2.24 (2.13–2.35)	1.69 (1.61–1.78)	1.50 (1.42–1.59)
Baseline disease + Hypertension	5.31 (3.58–7.89)	3.82 (2.57–5.67)	3.58 (2.41–5.33)	5.92 (4.24–8.25)	4.27 (3.06–5.95)	3.59 (2.57–5.03)
Baseline disease	4.81 (3.55–6.51)	3.82 (2.82–5.18)	3.48 (2.57–4.71)	3.59 (2.51–5.15)	2.83 (1.98–4.07)	2.71 (1.89–3.88)
DM	2.98 (2.91–3.17)	2.41 (2.27–2.56)	2.07 (1.4–2.20)	2.16 (1.98–2.35)	1.78 (1.63–1.94)	1.44 (1.32–1.58)
Baseline disease + DM	10.13 (6.61–15.53)	7.24 (4.72–11.12)	5.98 (3.89–9.19)	3.01 (1.88–6.15)	2.52 (1.39–4.56)	1.99 (1.10–3.61)
Baseline disease	5.28 (3.96–7.04)	4.13 (3.09–5.49)	3.68 (2.76–4.91)	3.77 (2.69–5.23)	2.91 (2.08–4.06)	2.61 (1.87–3.65)
Dyslipidemia	2.09 (1.96–2.23)	1.82 (1.71–1.94)	1.32 (1.23–1.42)	1.88 (1.73–2.05)	1.63 (1.49–1.78)	1.20 (1.09–1.32)
Baseline disease + Dyslipidemia	6.46 (3.95–10.55)	4.85 (2.97–7.93)	3.22 (1.97–5.27)	2.49 (1.12–5.55)	1.89 (0.85–4.23)*	1.27 (0.57–2.84)*

Model 1: not adjusted.

Model 2: adjusted for age and gender.

Model 3: adjusted for age, gender, income, residential area.

All P values < 0.001 except for^*.